Acceptance follows resolution of third-party fill/finish manufacturing issues
FDA decision expected by July 10, 2025
https://www.globenewswire.com/news-release/2025/02/11/3024043/0/en/Linvoseltamab-BLA-Accepted-for-FDA-Review-for-the-Treatment-of-Relapsed-Refractory-Multiple-Myeloma.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.